InMode Ltd.
Health
Performance
6.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

InMode Ltd. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

09.01.2026
Trouble brewing. Volatility and pressure rising.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.

InMode Ltd. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does InMode Ltd. do? Business model and key facts

Get the full picture of InMode Ltd.: what it builds, where it operates, and how it makes money.

InMode Ltd. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 599

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

shop
Company facts
Moshe Mizrahy
CEO
599
Employees worldwide
shop
Performance
-15.05%
Last 12 months
-51.4%
Last 5 years
shop
Growth
$394,82M
Revenue year
$181,28M
Net income
shop
Valuation
$938,11M
Market Cap
7.31
Price/Earnings Ratio

Stocks related to InMode Ltd.

Selected based on industry alignment and relative market positioning.

IART
Integra LifeSciences Holdings Corporation
12.53
-0.95%
8.4
Sell
Buy
Integra LifeSciences Holdings Corporation
CNMD
CONMED Corporation
41.91
-1.50%
6.6
Sell
Buy
CONMED Corporation
AXGN
AxoGen, Inc.
31.50
+0.90%
7.4
Sell
Buy
AxoGen, Inc.
SIBN
SI-BONE, Inc.
17.10
-2.73%
6.8
Sell
Buy
SI-BONE, Inc.
CTKB
Cytek Biosciences, Inc.
5.54
-1.35%
7.7
Sell
Buy
Cytek Biosciences, Inc.

InMode Ltd. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.